X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8417) 8417
Book Chapter (44) 44
Publication (20) 20
Dissertation (19) 19
Conference Proceeding (6) 6
Magazine Article (2) 2
Book / eBook (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
everolimus (6639) 6639
humans (5744) 5744
female (3262) 3262
male (3026) 3026
sirolimus - analogs & derivatives (2816) 2816
middle aged (2459) 2459
oncology (2278) 2278
aged (2026) 2026
treatment outcome (1928) 1928
cardiac & cardiovascular systems (1398) 1398
adult (1342) 1342
sirolimus - therapeutic use (1328) 1328
cancer (1210) 1210
drug-eluting stents (1199) 1199
sirolimus - administration & dosage (1185) 1185
transplantation (1079) 1079
rapamycin (1057) 1057
sirolimus (1037) 1037
surgery (974) 974
animals (961) 961
immunosuppressive agents - therapeutic use (943) 943
tor serine-threonine kinases - antagonists & inhibitors (930) 930
antineoplastic agents - therapeutic use (899) 899
care and treatment (862) 862
mtor (837) 837
mammalian target (831) 831
time factors (808) 808
sirolimus - pharmacology (739) 739
sunitinib (733) 733
everolimus - administration & dosage (710) 710
efficacy (705) 705
analysis (699) 699
metastasis (693) 693
therapy (651) 651
follow-up studies (650) 650
risk factors (648) 648
pharmacology & pharmacy (647) 647
everolimus - therapeutic use (644) 644
survival (623) 623
tumors (623) 623
carcinoma, renal cell - drug therapy (618) 618
sirolimus - adverse effects (615) 615
kidney neoplasms - drug therapy (612) 612
percutaneous coronary intervention (606) 606
prospective studies (595) 595
trial (593) 593
retrospective studies (589) 589
thrombosis (579) 579
stents (559) 559
angiogenesis inhibitors (555) 555
prosthesis design (550) 550
stent (527) 527
immunosuppressive agents - administration & dosage (521) 521
immunology (511) 511
medicine & public health (503) 503
abridged index medicus (493) 493
chemotherapy (493) 493
patients (488) 488
research (486) 486
aged, 80 and over (484) 484
clinical trials (482) 482
cell line, tumor (476) 476
prognosis (476) 476
antineoplastic combined chemotherapy protocols - therapeutic use (467) 467
cyclosporine (467) 467
tor serine-threonine kinases - metabolism (463) 463
immunosuppressive agents - adverse effects (462) 462
coronary artery disease - therapy (459) 459
interferon-alpha (457) 457
breast cancer (445) 445
tacrolimus (444) 444
double-blind (443) 443
kidney transplantation (442) 442
renal cell carcinoma (442) 442
urology & nephrology (441) 441
implantation (438) 438
safety (437) 437
absorbable implants (432) 432
coronary angiography (431) 431
sorafenib (429) 429
mice (427) 427
immunosuppressive agents - pharmacology (411) 411
health aspects (406) 406
disease-free survival (405) 405
expression (401) 401
outcomes (397) 397
temsirolimus (392) 392
cardiovascular agents - administration & dosage (385) 385
drug therapy (380) 380
kidney neoplasms - pathology (374) 374
mtor inhibitors (369) 369
drug therapy, combination (365) 365
multicenter (362) 362
antineoplastic agents - pharmacology (353) 353
signal transduction - drug effects (353) 353
everolimus - adverse effects (352) 352
everolimus - pharmacology (352) 352
immunotherapy (351) 351
targeted therapy (351) 351
follow-up (347) 347
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8173) 8173
French (117) 117
Japanese (105) 105
German (88) 88
Spanish (67) 67
Russian (44) 44
Chinese (13) 13
Portuguese (12) 12
Italian (11) 11
Hungarian (9) 9
Korean (9) 9
Polish (8) 8
Czech (7) 7
Norwegian (3) 3
Turkish (3) 3
Dutch (2) 2
Slovenian (2) 2
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The journal of clinical endocrinology and metabolism, ISSN 0021-972X, 2017, Volume 102, Issue 2, pp. 698 - 707
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2017, Volume 35, Issue 34, pp. 3851 - 3858
Purpose Combination treatment with immune checkpoint inhibitors has shown enhanced antitumor activity compared with monotherapy in tumor types such as... 
EVEROLIMUS | ONCOLOGY | Index Medicus
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 2017, Volume 72, Issue 6, pp. 962 - 971
Journal Article
Journal Article
Clinical cancer research, ISSN 1557-3265, 2016, Volume 22, Issue 22, pp. 5461 - 5471
Journal Article
Cancer discovery, ISSN 2159-8290, 2014, Volume 4, Issue 5, pp. 546 - 553
Journal Article
Molecular oncology, ISSN 1574-7891, 2017, Volume 11, Issue 8, pp. 1007 - 1022
textabstractMedullary thyroid cancer (MTC) is a tumor highly resistant to chemo- and radiotherapy. Drug resistance can be induced by epigenetic changes such as... 
NGFR | Neurotrophin pathway | Everolimus | Medullary thyroid cancer | MTOR | 5-aza-2'-deoxycytidine | medullary thyroid cancer | mTOR | neurotrophin pathway | everolimus | 5‐aza‐2′‐deoxycytidine | 5-aza-2′-deoxycytidine | 5-aza-2 '-deoxycytidine | CANCER-CELLS | NEUROTROPHIN RECEPTOR | NEUROENDOCRINE TUMORS | PANCREATIC-CANCER | MEDIATED APOPTOSIS | NERVE GROWTH-FACTOR | IN-VITRO | ONCOLOGY | SIGNALING PATHWAY | COLORECTAL-CANCER | TUMOR-SUPPRESSOR | Carcinoma, Neuroendocrine - metabolism | Genome-Wide Association Study | Everolimus - pharmacology | Neoplasm Proteins - biosynthesis | Carcinoma, Neuroendocrine - drug therapy | Humans | Azacitidine - analogs & derivatives | Azacitidine - agonists | Drug Synergism | Azacitidine - pharmacology | Thyroid Neoplasms - drug therapy | Carcinoma, Neuroendocrine - pathology | Gene Expression Regulation, Neoplastic - drug effects | Everolimus - agonists | Thyroid Neoplasms - metabolism | Thyroid Neoplasms - pathology | TOR protein | Bax protein | p53 Protein | Cytotoxicity | AKT protein | Genomes | Radiation therapy | Tumor cell lines | Drug resistance | Western blotting | 1-Phosphatidylinositol 3-kinase | Thyroid carcinoma | Signal transduction | Cell growth | Thyroid cancer | Nerve growth factor receptors | DNA methylation | Extracellular matrix | Mutation | Neuroendocrine tumors | Thyroid | Apoptosis
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 2010, Volume 120, Issue 8, pp. 2858 - 2866
Journal Article